$10.24
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqGM:IOVA
Iovance Biotherapeutics Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.19M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | $-1.27 | $-1.23 | $-0.62 | $-0.62 | $-0.48 | $-3.47 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
256.14m | 187.81m | 157m | 146.87m | 126.41m | 123.42m | 73.16m | 62.25m | 48.55m | 33.75m | 20.02m | |
| OCF | Operating Cash Flow |
|
$-361.82M | $-292.76M | $-227.94M | $-205.13M | $-158.89M | $-101.25M | $-78.71M | $-32.67M | $-18.38M | $-8.63M | $-3.66M | |
| FCF | Free Cash Flow |
|
$-372.00M | $-313.18M | $-265.52M | $-251.93M | $-165.81M | $-102.45M | $-91.72M | $-34.19M | $-19.52M | $-10.23M | $-3.67M | |
| FCFS | Free Cash Flow Per Share |
|
$-1.63 | $-1.97 | $-1.73 | $-1.82 | $-1.33 | $-1.05 | $-1.22 | $-0.62 | $-0.44 | $-0.41 | $-0.38 |
